Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Sera Prognostics, Inc. (SERA)  
$9.26 0.53 (5.41%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,290,000
Market Cap: 271.23(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.55 - $11.69
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Sera Prognostics is a women's health company. Co.'s primary commercial product, the PreTRM test, is a commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during week 19 or 20 of gestation that provides a prediction of the expectant mother's risk of delivering spontaneously before 37 weeks' gestation. Co. is discovering and developing several additional biomarker tests to predict other conditions of pregnancy, such as preeclampsia, and gestational diabetes, among others.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 8,000
Total Buy Value $0 $0 $0 $9,600
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 212,353 287,115 292,115 325,090
Total Sell Value $1,998,464 $2,554,554 $2,570,704 $2,624,320
Total People Sold 6 6 6 6
Total Sell Transactions 17 25 26 40
End Date 2024-02-13 2023-11-12 2023-05-14 2022-05-14

   
Records found: 78
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jackson Benjamin General Counsel   •       –      –    2022-06-14 4 B $1.20 $9,600 D/D 8,000 8,000 2.74 15%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-14 4 AS $1.21 $3,297 D/D (2,725) 62,860 15%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-07 4 AS $1.30 $3,543 D/D (2,725) 65,585 15%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-01 4 AS $1.36 $1,360 D/D (1,000) 68,310 30%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-01 4 OE $0.73 $730 D/D 1,000 69,310     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-31 4 AS $1.45 $3,951 D/D (2,725) 68,310 23%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-24 4 AS $1.54 $4,197 D/D (2,725) 71,035 18%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-17 4 AS $1.55 $4,224 D/D (2,725) 73,760 10%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-10 4 AS $1.97 $5,368 D/D (2,725) 76,485 -18%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-04 4 AS $2.17 $2,170 D/D (1,000) 79,210 -18%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-04 4 OE $0.73 $730 D/D 1,000 80,210     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-05-03 4 AS $2.17 $5,913 D/D (2,725) 79,210 -5%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-04-26 4 AS $2.17 $5,913 D/D (2,725) 81,935 -24%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-04-19 4 AS $2.08 $5,668 D/D (2,725) 84,660 -1%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-04-12 4 AS $2.66 $7,249 D/D (2,725) 87,385 -15%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-04-06 4 AS $3.02 $3,020 D/D (1,000) 90,110 -22%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-04-06 4 OE $0.73 $730 D/D 1,000 91,110     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-04-05 4 AS $3.35 $9,129 D/D (2,725) 90,110 -22%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-03-29 4 AS $3.73 $10,164 D/D (2,725) 92,835 -41%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-03-22 4 AS $3.68 $10,028 D/D (2,725) 95,560 -39%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-03-14 4 AS $3.94 $10,737 D/D (2,725) 98,285 -52%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-03-11 4 OE $0.73 $55,479 D/D 75,998 101,010     -
   Boniface John J. Chief Scientific Officer   •       –      –    2021-12-06 4 OE $0.73 $18,259 D/D 25,012 25,012     -
   Critchfield Gregory C Chief Executive Officer   •       •      –    2021-07-19 4 A $0.00 $0 D/D 84,973 794,945     -
   Trimble Ryan Director   –       •      –    2021-07-19 4 A $0.00 $0 I/I 63,005 100,554     -
  78 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us